238 related articles for article (PubMed ID: 16392821)
1. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
[TBL] [Abstract][Full Text] [Related]
3. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.
Muth M; Sennwitz M; Mohr K; Holzgrabe U
J Med Chem; 2005 Mar; 48(6):2212-7. PubMed ID: 15771463
[TBL] [Abstract][Full Text] [Related]
5. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
6. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
[TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
9. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
10. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic allosteric modulators: atypical structure-activity-relationships in bispyridinium-type compounds.
Sürig U; Gaal K; Kostenis E; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2006 Apr; 339(4):207-12. PubMed ID: 16572483
[TBL] [Abstract][Full Text] [Related]
12. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
May LT; Lin Y; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
[TBL] [Abstract][Full Text] [Related]
13. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
Lanzafame AA; Sexton PM; Christopoulos A
Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
15. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
16. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
Avlani V; May LT; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
[TBL] [Abstract][Full Text] [Related]
18. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
[TBL] [Abstract][Full Text] [Related]
19. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
Staudt M; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2003 Aug; 336(8):385-9. PubMed ID: 14502759
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M.
Dallanoce C; Conti P; De Amici M; De Micheli C; Barocelli E; Chiavarini M; Ballabeni V; Bertoni S; Impicciatore M
Bioorg Med Chem; 1999 Aug; 7(8):1539-47. PubMed ID: 10482446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
